Health resource utilization, costs, and community treatment order status before and after the initiation of second-generation long acting-injectable antipsychotics in patients with schizophrenia in Alberta, Canada
Introduction Long-acting injectable (LAI) antipsychotics and community treatment orders (CTOs) are used in patients with schizophrenia to improve treatment effectiveness through adherence. Objectives Understanding healthcare resource utilization (HRU) and associated costs, and medication adherence...
Main Authors: | P. Chue, K.O. Wong, S. Klarenbach, K. Martins, S. Dursun, M. Snaterse, L. Richer |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822003261/type/journal_article |
Similar Items
-
The combination of long-acting injectable antipsychotics, a new key in resistant schizophrenia
by: M.F. Tascón Guerra, et al.
Published: (2022-06-01) -
Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review
by: Ma N, et al.
Published: (2023-09-01) -
Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations
by: Orietta Zaniolo, et al.
Published: (2019-02-01) -
Schizophrenia long-acting antipsychotics initiation index (SLAAII)
by: P. Ifteni, et al.
Published: (2021-04-01) -
Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland
by: Stephan Reymann, et al.
Published: (2022-03-01)